Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

Autor: Coleman RL; US Oncology Research, The Woodlands, TX, USA. Electronic address: rcoleman@gog.org., Lorusso D; Multicentre Italian Trials in Ovarian Cancer and Gynaecological Malignancies Group and Scientific Directorate and Department of Women and Child Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Gennigens C; Department of Medical Oncology, Centre Hospitalier Universitaire de Liège, Liège, Belgium., González-Martín A; Grupo Español de Investigación en Cáncer de Ovario and Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain., Randall L; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA., Cibula D; Central and Eastern European Gynecologic Oncology Group and Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Lund B; Aalborg University Hospital, Aalborg, Denmark., Woelber L; Arbeitsgemeinschaft Gynäkologische Onkologie Study Group and University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Pignata S; Multicentre Italian Trials in Ovarian Cancer and Gynaecological Malignancies Group and Istituto Nazionale per lo Studio e la Cura dei Tumori, 'Fondazione G Pascale' IRCCS, Naples, Italy., Forget F; Centre Hospitalier de l'Ardenne, Libramont, Belgium., Redondo A; Grupo Español de Investigación en Cáncer de Ovario and Hospital Universitario La Paz-IdiPAZ, Madrid, Spain., Vindeløv SD; Genmab, Copenhagen, Denmark., Chen M; Genmab US, Princeton, NJ, USA., Harris JR; Genmab US, Princeton, NJ, USA., Smith M; Genmab US, Princeton, NJ, USA., Nicacio LV; Seagen, Bothell, WA, USA., Teng MSL; Seagen, Bothell, WA, USA., Laenen A; Belgium and Luxembourg Gynaecological Oncology Group and University of Leuven, Leuven Cancer Institute, Leuven, Belgium., Rangwala R; Genmab US, Princeton, NJ, USA., Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain., Mirza M; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, USA., Vergote I; Belgium and Luxembourg Gynaecological Oncology Group and University of Leuven, Leuven Cancer Institute, Leuven, Belgium.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2021 May; Vol. 22 (5), pp. 609-619. Date of Electronic Publication: 2021 Apr 09.